BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27562393)

  • 21. Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.
    Shah SU; Mashayekhi A; Shields CL; Walia HS; Hubbard GB; Zhang J; Shields JA
    Ophthalmology; 2014 Jan; 121(1):352-357. PubMed ID: 23988200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit.
    Finger PT; Tena LB; Semenova E; Aridgides P; Choi WH
    Brachytherapy; 2014; 13(3):275-80. PubMed ID: 24139892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciliary body medulloepithelioma: analysis of 41 cases.
    Kaliki S; Shields CL; Eagle RC; Vemuganti GK; Almeida A; Manjandavida FP; Mulay K; Honavar SG; Shields JA
    Ophthalmology; 2013 Dec; 120(12):2552-2559. PubMed ID: 23796765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan.
    Jaradat I; Zewar A; AlNawaiseh I; AlRawashdeh K; Khurma S; Mehyar M; Abdeen G; Yousef YA
    Saudi J Ophthalmol; 2018; 32(2):130-133. PubMed ID: 29942182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
    Shields CL; Furuta M; Thangappan A; Nagori S; Mashayekhi A; Lally DR; Kelly CC; Rudich DS; Nagori AV; Wakade OA; Mehta S; Forte L; Long A; Dellacava EF; Kaplan B; Shields JA
    Arch Ophthalmol; 2009 Aug; 127(8):989-98. PubMed ID: 19667335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Failures of brachytherapy in posterior uveal melanoma].
    Starzycka M; Stachura J; Romanowska-Dixon B; Heitzman J
    Klin Oczna; 2000; 102(2):89-94. PubMed ID: 10932887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
    Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
    Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
    Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
    Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and histopathological features of choroidal melanoma-related enucleated eyes in a Spanish tertiary hospital.
    García Tirado A; Asencio Durán M; Berjón A; Ruiz Bravo-Burguillos E; Peralta Calvo J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):225-231. PubMed ID: 30904338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ring melanoma of the anterior chamber angle: a report of fourteen cases.
    Demirci H; Shields CL; Shields JA; Eagle RC; Honavar S
    Am J Ophthalmol; 2001 Sep; 132(3):336-42. PubMed ID: 11530045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
    Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
    Fabian ID; Tomkins-Netzer O; Stoker I; Arora AK; Sagoo MS; Cohen VM
    Am J Ophthalmol; 2015 Dec; 160(6):1104-1110.e1. PubMed ID: 26344583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uveal melanomas. Conservation treatment.
    Munzenrider JE
    Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
    Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
    Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.